Reply to: RIPK3 in acutely decompensated cirrhosis: prognostic promise and analytic pitfalls.

IF 33 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-10-10 DOI:10.1016/j.jhep.2025.10.003

Pratibha Garg, Nipun Verma, Rajiv Jalan

{"title":"Reply to: RIPK3 in acutely decompensated cirrhosis: prognostic promise and analytic pitfalls.","authors":"Pratibha Garg, Nipun Verma, Rajiv Jalan","doi":"10.1016/j.jhep.2025.10.003","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Uncited reference</h2>5..</section></section><section><section><h2>Authors' contributions</h2>Conceptualization: NV, RJ, Analysis: PG, Writing original draft: PG, NV, RJ, Writing-review and edits: RJ, NV</section></section><section><section><h2>Data availability statement</h2>The data generated and analysed during the current study are included in this published article or available from the corresponding author on reasonable request.</section></section><section><section><h2>Financial support</h2>This study was partly supported by the Indian Council of Medical Research (ICMR, 5/4/3-1/Gastro/2022-NCD-11 and NCD/Adhoc/129/2021-22 awarded to NV).</section></section><section><section><h2>Conflict of interest</h2>RJ: has research collaborations with Yaqrit. He is a founder of Yaqrit limited, a spin out company from University College London (<span><span>www.yaqrit.com</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>). He has also co-founded Cyberliver Ltd (<span><span>www.cyberliver.com</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>). Other authors declare no conflicts of interest.</section></section><section><section><h2>Acknowledgement</h2>None</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"12 1","pages":""},"PeriodicalIF":33.0000,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2025.10.003","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Section snippets

Uncited reference

5..

Authors' contributions

Conceptualization: NV, RJ, Analysis: PG, Writing original draft: PG, NV, RJ, Writing-review and edits: RJ, NV

Data availability statement

The data generated and analysed during the current study are included in this published article or available from the corresponding author on reasonable request.

Financial support

This study was partly supported by the Indian Council of Medical Research (ICMR, 5/4/3-1/Gastro/2022-NCD-11 and NCD/Adhoc/129/2021-22 awarded to NV).

Conflict of interest

RJ: has research collaborations with Yaqrit. He is a founder of Yaqrit limited, a spin out company from University College London (www.yaqrit.com). He has also co-founded Cyberliver Ltd (www.cyberliver.com). Other authors declare no conflicts of interest.

Acknowledgement

None

查看原文本刊更多论文

RIPK3在急性失代偿期肝硬化中的应用：预后前景和分析缺陷。

引用的参考文献5..作者的贡献概念：NV， RJ，分析：PG，写作原稿：PG， NV， RJ，写作-审查和编辑：RJ， nv数据可用性声明本研究中产生和分析的数据包含在本文中，或应通讯作者的合理要求提供。本研究得到了印度医学研究委员会的部分资助（ICMR， 5/4/3-1/Gastro/2022-NCD-11和NCD/Adhoc/129/2021-22授予NV）。利益冲突j：与雅虎有研究合作。他是伦敦大学学院（University College London）分拆出来的公司Yaqrit limited （www.yaqrit.com）的创始人。他还共同创立了Cyberliver Ltd （www.cyberliver.com）。其他作者声明没有利益冲突。AcknowledgementNone

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.